当前位置: X-MOL 学术BMC Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex.
BMC Immunology ( IF 2.9 ) Pub Date : 2020-03-20 , DOI: 10.1186/s12865-020-00343-2
Susanne Axelsson 1 , Anders Magnuson 2 , Anna Lange 3 , Aseel Alshamari 4 , Elisabeth Hultgren Hörnquist 5 , Olof Hultgren 4
Affiliation  

The use of anti-B cell based therapies in immune-mediated diseases targeting general B cell markers or molecules important for B cell function has increased the clinical needs of monitoring B cell subpopulations. We analyzed the expression profile of cell surface markers CD86 and B and T lymphocyte attenuator (BTLA) in B cell subtypes using flow cytometry, including naïve, transitional, switched memory, non-switched memory and double-negative memory B cells and plasmablasts, and investigated the dependence of age and sex in a healthy adult blood donor population. The switched memory B cell subtype displayed a divergent expression of the markers, with increased CD86 and decreased BTLA as compared to non-switched and double negative memory cells, as well as compared to naïve B cells. Plasmablasts expressed highly increased CD86 compared to all other subtypes and a decreased expression of BTLA compared to naïve cells, but still higher compared to the memory cell populations. Transitional B cells had CD86 and BTLA expression similar to the other naïve cells. We show divergent expression of CD86 and BTLA in memory cells and plasmablasts compared to naïve B cells independent of age and sex. Furthermore, a similarly divergent difference of expression pattern was seen between the memory cell subtypes, altogether indicating that the combination of CD86 and BTLA might be markers for a permissive activation state. We suggest the combination of CD86 and BTLA expression on B cell subtypes as a potentially important tool in monitoring the status of B cell subtypes before and after treatments influencing the B cell compartment.

中文翻译:

激活标记CD86与免疫检查点标记B和T淋巴细胞减毒剂(BTLA)的组合表明健康献血者中B细胞亚型的假定的许可激活状态,与年龄和性别无关。

在针对一般B细胞标记或对B细胞功能重要的分子的免疫介导疾病中使用基于抗B细胞的疗法增加了监测B细胞亚群的临床需求。我们使用流式细胞仪分析了B细胞亚型中细胞表面标志物CD86和B和T淋巴细胞减毒剂(BTLA)的表达谱,包括幼稚,过渡,开关记忆,非开关记忆和双阴性记忆B细胞和浆母细胞,以及研究了健康成年献血者年龄和性别的依赖性。与未切换和双重阴性记忆细胞相比,与未处理的B细胞相比,切换的记忆B细胞亚型表现出不同的标志物表达,CD86增加且BTLA降低。与所有其他亚型相比,成浆细胞表达的CD86高度增加,而与幼稚细胞相比,成纤维细胞的BTLA表达降低,但与记忆细胞群体相比仍更高。过渡性B细胞的CD86和BTLA表达与其他幼稚细胞相似。我们显示,与年龄和性别无关的幼稚B细胞相比,CD86和BTLA在记忆细胞和成浆细胞中表达不同。此外,在记忆细胞亚型之间观察到类似的表达模式差异,共同表明CD86和BTLA的组合可能是允许激活状态的标志。我们建议将CD86和BTLA表达结合在B细胞亚型上,作为监测影响B细胞区室的治疗前后B细胞亚型状态的潜在重要工具。
更新日期:2020-04-22
down
wechat
bug